1	Mujer	mujer	NCFS000	C0043210#C0015780#C0086418	persona#hallazgo#estructura_corporal#organismo_vivo	0-5	294_QUEST_clinical_caseMIR	SENT1	-	-
2	de	de	SPS00	C0332285	atributo	6-8	294_QUEST_clinical_caseMIR	SENT1	-	-
3	24	24		-	-	9-11	294_QUEST_clinical_caseMIR	SENT1	-	-
4	años	año	NCMP000	C0439234	calificador	12-16	294_QUEST_clinical_caseMIR	SENT1	-	-
5	con	con	SPS00	C0332287	atributo	17-20	294_QUEST_clinical_caseMIR	SENT1	-	-
6	dos	dos		-	-	21-24	294_QUEST_clinical_caseMIR	SENT1	-	-
7	episodios	episodio	NCMP000	C0332189	atributo	25-34	294_QUEST_clinical_caseMIR	SENT1	-	-
8	semanales	semanal	AQ0CP0	C0332174	calificador	35-44	294_QUEST_clinical_caseMIR	SENT1	-	-
9	de	de	SPS00	C0332285	atributo	45-47	294_QUEST_clinical_caseMIR	SENT1	-	-
10	cefalea	cefalea	NCFS000	C0018681	hallazgo	48-55	294_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
11	de	de	SPS00	C0332285	atributo	56-58	294_QUEST_clinical_caseMIR	SENT1	-	-
12	entre	entre	SPS00	C0205103	calificador	59-64	294_QUEST_clinical_caseMIR	SENT1	-	-
13	uno	uno		C0205447_1	calificador_1	65-68	294_QUEST_clinical_caseMIR	SENT1	-	-
14	y	y	CC	C1706368	calificador	69-70	294_QUEST_clinical_caseMIR	SENT1	-	-
15	tres	tres		-	-	71-75	294_QUEST_clinical_caseMIR	SENT1	-	-
16	días	día	NCMP000	C0439228#C0332169	calificador	76-80	294_QUEST_clinical_caseMIR	SENT1	-	-
17	de	de	SPS00	C0332285	atributo	81-83	294_QUEST_clinical_caseMIR	SENT1	-	-
18	duración	duración	NCFS000	C0449238	atributo	84-92	294_QUEST_clinical_caseMIR	SENT1	-	-
19	,	,	Fc	-	-	92-93	294_QUEST_clinical_caseMIR	SENT1	-	-
20	hemicraneal	hemicraneal	NC00BB0	-	-	94-105	294_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-
21	,	,	Fc	-	-	105-106	294_QUEST_clinical_caseMIR	SENT1	-	-
22	intensa	intenso	AQ0FS0	C0205178	calificador	107-114	294_QUEST_clinical_caseMIR	SENT1	B-Calificador	-
23	,	,	Fc	-	-	114-115	294_QUEST_clinical_caseMIR	SENT1	-	-
24	acompañada	acompañar	VMP00SF	-	-	116-126	294_QUEST_clinical_caseMIR	SENT1	-	-
25	de	de	SPS00	C0332285	atributo	127-129	294_QUEST_clinical_caseMIR	SENT1	-	-
26	sono	sono	NCMS000	-	-	130-134	294_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
27	y	y	CC	C1706368	calificador	135-136	294_QUEST_clinical_caseMIR	SENT1	-	-
28	fotofobia	fotofobia	NCFS000	C0085636	hallazgo	137-146	294_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
29	y	y	CC	C1706368	calificador	147-148	294_QUEST_clinical_caseMIR	SENT1	-	-
30	náuseas	náusea	NCFP000	-	-	149-156	294_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
31	.	.	Fp	-	-	156-157	294_QUEST_clinical_caseMIR	SENT1	-	-

1	Como	como	CS	C0332257	calificador	158-162	294_QUEST_clinical_caseMIR	SENT2	-	-
2	tratamiento	tratamiento	NCMS000	C0199176#C0199175_1	procedimiento_1	163-174	294_QUEST_clinical_caseMIR	SENT2	-	-
3	preventivo	preventivo	AQ0MS0	C0199176#C0199175_2	procedimiento_2	175-185	294_QUEST_clinical_caseMIR	SENT2	-	-
4	NO	no	RN	C1298908	calificador	186-188	294_QUEST_clinical_caseMIR	SENT2	-	-
5	consideraría	considerar	VMIC3S0	-	-	189-201	294_QUEST_clinical_caseMIR	SENT2	-	-
6	uno	uno		C0205447_1	calificador_1	202-205	294_QUEST_clinical_caseMIR	SENT2	-	-
7	de	de	SPS00	C0332285	atributo	206-208	294_QUEST_clinical_caseMIR	SENT2	-	-
8	estos	este	DD0MP0	-	-	209-214	294_QUEST_clinical_caseMIR	SENT2	-	-
9	fármacos	fármaco	NCMP000	C0013227	sustancia	215-223	294_QUEST_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
10	:	:	Fd	-	-	223-224	294_QUEST_clinical_caseMIR	SENT2	-	-
11	.	.	Fp	-	-	224-225	294_QUEST_clinical_caseMIR	SENT2	-	-

